言語を選択

Postfusion glycoprotein F0/post-F protein (RSV)

Postfusion glycoprotein F0/post-F protein (RSV) 製品リスト

属性
Protein (2)Antibody (2)
製品ライブラリ
オンライン (4)
種
Human respiratory syncytial virus A (strain A2) (1)Human respiratory syncytial virus B (strain B1) (1)Mouse (2)
タグ
His Tag (2)- (2)
マーカー
Unconjugated (4)

製品番号	種	発現システム	製品説明
HOT RSV-M662	Mouse	HEK293	Monoclonal Anti-RSV-post-F0 specific Antibody, Human IgG1 (1A2D9D8) (MALS verified)
HOT RSF-V52H6	Human respiratory syncytial virus A (strain A2)	HEK293	HRSV (A) Post-fusion glycoprotein F0, His Tag (MALS verified)
HOT RSF-V52H9	Human respiratory syncytial virus B (strain B1)	HEK293	HRSV (B) Post-fusion glycoprotein F0, His Tag (MALS verified)
RSV-Y180	Mouse	Hybridoma	Monoclonal Anti-RSV-post-F0 specific Antibody, Mouse IgG1 (1A2D9D8) (MALS verified)

総数量4

Postfusion glycoprotein F0/post-F protein (RSV)バックグランド

Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation.

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
RGN-259	Fx peptide; TB4 16-38; RGN-457; Thymosin beta 4-16-38; Thymosin B4; RGN-352; RGN-259; RGN-137; Tβ4; TB4; GBT-201; GBT-101; Thymosin beta4	Phase 3 Clinical	National Institutes Of Health	Keratitis; Myocardial Ischemia; ST Elevation Myocardial Infarction; Myocardial Infarction; Graft vs Host Disease; Sjogren's Syndrome; Dry Eye Syndromes; Epidermolysis Bullosa; Pressure Ulcer; Epidermolysis Bullosa, Junctional; Varicose Ulcer; Diabetes Mellitus; Epidermolysis Bullosa Dystrophica	詳細
Fasinumab	SAR-164877; MT-5547; R-475; REGN-475	Phase 3 Clinical		Abdominal Pain; Sciatica; Osteoarthritis, Knee; Back Pain; Osteoarthritis; Low Back Pain; Osteoarthritis, Hip	詳細
MEDI-7352	MEDI-7352	Phase 2 Clinical	Medimmune	Chronic Pain; Diabetic Neuropathies; Osteoarthritis, Knee	詳細
N-Hexacosanol	tCFA15; TAC-302	Phase 2 Clinical	Meiji Seika Pharma Co Ltd	Urinary Bladder, Underactive; Urinary Bladder, Overactive	詳細
Antibodies to humanized nerve growth factor(Shenyang Sunshine Pharmaceutical)		Phase 2 Clinical	Shenyang Sunshine Pharmaceutical Co Ltd	Bone metastases; Cancer Pain	詳細
EP-9001A	EP-9001A	Phase 2 Clinical	Chengdu Youluo Biotechnology Co Ltd	Bone metastases; Cancer Pain; Pain	詳細
DS-002	DS-002	Phase 2 Clinical	Dartsbio Pharmaceuticals Ltd	Pain; Cancer Pain	詳細
Atinumab	NG-101; ATI-355	Phase 2 Clinical	Novartis Pharma Ag	Spinal Cord Injuries; Gastroparesis; Diabetic Gastroparesis	詳細
SSS-40	SSS-40; SSS-40-anti-NGF Ab; SSS40 anti-NGF Ab	Phase 1 Clinical	3sbio Inc	Cancer Pain; Bone Neoplasms; Osteoarthritis	詳細
Luvagrobart	AK-115	Phase 1 Clinical	Zhongshan Akeso Biopharma Co Ltd	Pain; Cancer Pain	詳細
TNM-009	TNM-009; TNM009	Phase 1 Clinical	Zhuhai Trinomab Pharmaceutical Co Ltd	Cancer Pain; Pain	詳細
SMR-7694	SMR-7694; SMR7694	Phase 1 Clinical	Sinobioway Biomedicine Co Ltd	Osteoarthritis	詳細
Neuroregenerative agents (iNtRON Biotechnology)		Clinical	Intron Biotechnology	Nervous System Diseases	詳細